VILELLA, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 6.249
AS - Asia 3.605
EU - Europa 3.056
SA - Sud America 543
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 9
Totale 13.568
Nazione #
US - Stati Uniti d'America 6.087
SG - Singapore 1.091
CN - Cina 982
IT - Italia 955
GB - Regno Unito 932
BR - Brasile 422
HK - Hong Kong 419
VN - Vietnam 412
DE - Germania 211
SE - Svezia 208
FI - Finlandia 144
KR - Corea 140
RU - Federazione Russa 130
FR - Francia 96
TR - Turchia 96
BD - Bangladesh 95
IN - India 88
UA - Ucraina 85
CA - Canada 71
ID - Indonesia 56
MX - Messico 52
AR - Argentina 46
NL - Olanda 45
BG - Bulgaria 42
ZA - Sudafrica 39
ES - Italia 34
JP - Giappone 34
LT - Lituania 28
IQ - Iraq 27
IE - Irlanda 26
PL - Polonia 22
BE - Belgio 20
EC - Ecuador 20
PK - Pakistan 20
CL - Cile 18
CO - Colombia 18
AT - Austria 16
AE - Emirati Arabi Uniti 15
UZ - Uzbekistan 15
MY - Malesia 14
RO - Romania 12
IR - Iran 11
TN - Tunisia 10
IL - Israele 9
JO - Giordania 9
NO - Norvegia 9
PH - Filippine 9
SA - Arabia Saudita 9
AU - Australia 8
DZ - Algeria 8
EU - Europa 8
CU - Cuba 7
EG - Egitto 7
KZ - Kazakistan 7
MA - Marocco 7
TH - Thailandia 7
AN - Antille olandesi 6
DO - Repubblica Dominicana 6
KE - Kenya 6
LB - Libano 6
PY - Paraguay 6
VE - Venezuela 6
AL - Albania 5
AZ - Azerbaigian 5
CH - Svizzera 5
NP - Nepal 5
PA - Panama 5
PT - Portogallo 5
TW - Taiwan 5
AO - Angola 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
JM - Giamaica 4
OM - Oman 4
SN - Senegal 4
BH - Bahrain 3
ET - Etiopia 3
HN - Honduras 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
EE - Estonia 2
GR - Grecia 2
HU - Ungheria 2
KW - Kuwait 2
MD - Moldavia 2
PR - Porto Rico 2
TG - Togo 2
UY - Uruguay 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
CY - Cipro 1
Totale 13.552
Città #
Ashburn 738
Southend 679
Santa Clara 620
Singapore 599
Fairfield 471
Hong Kong 413
Chandler 384
Hefei 371
Woodbridge 293
San Jose 268
Houston 218
Seattle 214
Modena 211
Beijing 194
Ann Arbor 179
Chicago 178
Wilmington 172
Cambridge 151
Dearborn 140
Los Angeles 139
Ho Chi Minh City 137
Nyköping 135
London 129
Seoul 128
Jacksonville 124
Helsinki 105
Hanoi 93
New York 92
Council Bluffs 87
The Dalles 82
Bologna 62
Como 55
Munich 51
Milan 48
Izmir 46
Lauterbourg 43
Princeton 42
Salt Lake City 42
São Paulo 42
Jakarta 40
Sofia 40
San Diego 37
Moscow 35
Buffalo 33
Eugene 33
Dallas 32
Parma 32
Orem 31
Rome 29
Chennai 28
Reggio Emilia 28
Redwood City 26
Tokyo 26
Frankfurt am Main 24
Kocaeli 22
Da Nang 21
Guangzhou 21
Mexico City 21
Brooklyn 20
Shanghai 20
Johannesburg 19
Atlanta 18
Boston 18
Montreal 18
Phoenix 18
Warsaw 18
Dublin 17
Elk Grove Village 17
Fremont 17
Tampa 17
Columbus 16
Haiphong 16
Stockholm 16
Brussels 14
Poplar 14
Toronto 14
Amsterdam 13
Brasília 13
Bremen 13
Manchester 13
Quito 13
Tashkent 13
Boardman 12
Redondo Beach 12
Sterling 12
Tulare 12
Zhengzhou 12
Baghdad 11
Lancaster 11
Nuremberg 11
Kent 10
Norwalk 10
Ottawa 10
Santiago 10
Turku 10
Vancouver 10
Buenos Aires 9
Denver 9
Formigine 9
Miami 9
Totale 9.308
Nome #
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 435
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 424
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 391
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 366
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 364
Activity and circadian rhythm influence synaptic Shank3 protein levels in mice 363
LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response 361
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 357
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 353
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 333
Heterosynaptic GABAergic plasticity bidirectionally driven by the activity of pre- and postsynaptic NMDA receptors 331
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 327
Distribution and relative abundance of S100 proteins in the brain of the APP23 Alzheimer’s disease model mice 320
In vivo study of the role of a6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin 314
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 314
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 309
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 306
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 305
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 304
Astrocyte-targeted production of IL-10 induces changes in microglial reactivity and reduces motor neuron death after facial nerve axotomy 293
DAT atypical inhibitors as novel antipsychotic drugs 278
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 270
A regional and cellular analysis of the early intracellular and extracellular accumulation of Aβ in the brain of 5XFAD mice 266
Brain targeting by engineered nanoparticles 262
Neuronal and extraneuronal nicotinic acetylcholine receptors 258
Bioresorbable Nanostructured Chemical Sensor for Monitoring of pH Level In Vivo 255
Nanomedicine in Neuroscience: the potential of targeted nanoparticles in crossing the Blood-Brain Barrier 253
Nanoparticles and the BBB crossing: in vivo and in vitro upcomings 253
Nano-Neuroscience: Targeted nanoparticles For CNS drug delivery 250
Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice 247
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 245
Nanotechnology and Central Nervous System Drug Delivery 242
Rab5-dependent cell-specific uptake and distribution of engineered nanoparticles for CNS targeted drug delivery in vivo 229
Alterations in microglial phenotype and hippocampal neuronal function in transgenic mice with astrocyte-targeted production of interleukin-10 228
PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer’s Disease 221
Nanomedicine in Neuroscience: The potential of targeted nanoparticles in neurodegenerative disorders 209
Dorsal and ventral striatal neuronal subpopulations differentially disrupt male mouse copulatory behavior 195
Female mice exhibit similar long-term plasticity and microglial properties between the dorsal and ventral hippocampal poles 192
S100B dysregulation during brain development affects synaptic SHANK protein networks via alteration of zinc homeostasis 183
Implantable and Bioresorbable Nanostructured Fluorescence Sensor for In vivo pH Monitoring 173
Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease 173
Targeting Metal Homeostasis as a Therapeutic Strategy for Alzheimer’s Disease 171
Hydroxypropyl-β-Cyclodextrin Depletes Membrane Cholesterol and Inhibits SARS-CoV-2 Entry into HEK293T-ACEhi Cells 170
MicroRNA-218 instructs proper assembly of hippocampal networks 161
Evidence for a protective effect of the loss of α4-containing nicotinic acetylcholine receptors on Aβ-related neuropathology in Tg2576 mice 158
Nanomedicine in neurodegenerative disorders: Understanding the journey 152
Placebo effect between evidence and myths: How to distinguish true from fake news 144
Long-term behavioral and histological profile following CA3 ventral lesion 140
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 132
The Role of Trace Metals in Alzheimer’s Disease 129
Two minimally invasive strategies to implant guide cannulas for multiple injections in deep brain areas 122
Targeted metabolomics for the analysis of p-cresol in mouse brain by HPLC-ESI-MS/MS 117
Targeted Metabolomics for the Analysis of p-Cresol in Mouse Brain: Impact of Biological Sex and Strain 108
Targeted metabolomics for the analysis of p-Cresol in mouse brain by HPLC-ESI-MS/MS 103
Una nuova strategia per ingannare la barriera emato-encefalica: studio in vivo di captazione, distribuzione e trasporto di nanoparticelle nel cervello. 69
Reference gene variability across age and sex in 5XFAD mice highlights normalization challenges in Alzheimer’s models 25
Thermally Degradable Biocompatible Hydrogel as Transient Encapsulation Coating for Implantable Sensors 16
Multiparametric Bioresorbable Sensor for Doxorubicin Detection via Molecularly Imprinted Synthetic Receptors 12
DevelopmentofaBiodegradableGreenEmitterChitosan-Based OLEDfor ImplantableBiomedicalDevices 6
In vivo and in situ monitoring of doxorubicin pharmacokinetics with an implantable bioresorbable optical sensor. 6
Totale 13.693
Categoria #
all - tutte 52.650
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.650


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021133 0 0 0 0 0 0 0 0 0 0 84 49
2021/2022850 39 50 87 38 28 37 33 67 101 78 170 122
2022/2023959 104 128 93 90 104 106 13 103 110 15 50 43
2023/2024696 29 33 59 77 149 51 64 78 16 15 48 77
2024/20252.626 95 26 56 160 434 368 222 162 212 194 353 344
2025/20265.092 394 202 382 672 958 322 562 256 533 522 289 0
Totale 13.693